The popularity of Viagra initially sparked a boom for pharma, however recent shifts present a uncertain picture for investors. Off-patent alternatives are eroding profits, and ongoing patent challenges add further https://haseebwxwl320730.blog-ezine.com/41739584/sildenafil-and-pharma-a-risky-investment